| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.004 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |